Natco Pharma Financials
NSE: NATCOPHARM | BSE: 524816
₹828.65
₹-9.65
(-1.15%)
As on 04-Sep-2026 15:59IST
Market cap
₹14,848 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13
P/B Ratio
1.6
Div. Yield
0.6 %
Income Statement (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
3,484.60
|
4,429.50
|
3,998.80
|
2,707.10
|
1,944.80
|
2,052.10
|
|
|
|
|
|
|
Total Income
|
3,779.70
|
4,786.20
|
4,126.90
|
2,835.60
|
2,043.80
|
2,158.10
|
|
|
|
|
|
|
Total Expenditure
|
2,432.60
|
2,235.70
|
2,247.40
|
1,795.40
|
1,681.30
|
1,448.30
|
|
|
|
|
|
|
EBITDA
|
1,052.00
|
2,193.80
|
1,751.40
|
911.70
|
263.50
|
603.80
|
|
|
|
|
|
|
Depreciation
|
196.10
|
235.20
|
186.80
|
163.80
|
142.60
|
116.90
|
|
|
|
|
|
|
EBIT
|
855.90
|
1,958.60
|
1,564.60
|
747.90
|
120.90
|
486.90
|
|
|
|
|
|
|
Interest
|
46.50
|
23.90
|
19.20
|
14.50
|
17.70
|
13.30
|
|
|
|
|
|
|
Other Income
|
295.10
|
356.70
|
128.10
|
128.50
|
99.00
|
106.00
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
1,104.50
|
2,291.40
|
1,673.50
|
861.90
|
202.20
|
579.60
|
|
|
|
|
|
|
Provision for Tax
|
90.70
|
408.00
|
285.20
|
146.60
|
32.20
|
137.20
|
|
|
|
|
|
|
Profit after Tax
|
1,013.80
|
1,883.40
|
1,388.30
|
715.30
|
170.00
|
442.40
|
|
|
|
|
|
|
Minority Interest
|
-0.40
|
2.00
|
--
|
--
|
--
|
-1.50
|
|
|
|
|
|
|
Share of Associate
|
130.90
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
1,144.30
|
1,885.40
|
1,388.30
|
715.30
|
170.00
|
440.90
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
9,221.10
|
7,607.00
|
5,853.10
|
4,873.80
|
4,263.60
|
4,121.60
|
|
|
|
|
|
|
Minority Interest
|
-0.40
|
5.30
|
--
|
--
|
--
|
1.80
|
|
|
|
|
|
|
Non-Current Liabilities
|
171.70
|
24.90
|
61.00
|
100.50
|
135.10
|
142.90
|
|
|
|
|
|
|
Current Liabilities
|
1,680.90
|
943.50
|
972.80
|
683.10
|
710.40
|
525.60
|
|
|
|
|
|
|
Total Liabilities
|
11,073.70
|
8,630.60
|
6,906.10
|
5,657.40
|
5,109.10
|
4,791.90
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
5,877.90
|
3,310.70
|
2,863.40
|
2,657.10
|
2,622.40
|
2,447.10
|
|
|
|
|
|
|
Current Assets
|
5,052.30
|
5,270.00
|
4,023.50
|
3,000.30
|
2,486.70
|
2,344.80
|
|
|
|
|
|
|
Total Assets
|
11,073.70
|
8,630.60
|
6,906.10
|
5,657.40
|
5,109.10
|
4,791.90
|
|
|
|
|
|
|
Total Debt*
|
--
|
273.10
|
363.20
|
165.00
|
404.00
|
265.80
|
|
|
|
|
|
|
Net Current Assets
|
3,371.40
|
4,326.50
|
3,050.70
|
2,317.20
|
1,776.30
|
1,819.20
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
3.00
|
0.40
|
14.60
|
8.00
|
1.20
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,696.80
|
1,211.60
|
849.10
|
46.50
|
298.80
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-1,414.50
|
-1,032.70
|
-477.10
|
-5.30
|
-103.30
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-210.70
|
-246.90
|
-363.00
|
34.80
|
-185.70
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
71.60
|
-68.00
|
9.00
|
76.00
|
9.80
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
63.89
|
105.33
|
77.56
|
39.19
|
9.32
|
24.16
|
|
|
|
|
|
|
Cash EPS (₹)
|
63.89
|
118.36
|
87.99
|
48.17
|
17.13
|
30.65
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
521.65
|
424.97
|
326.99
|
267.06
|
233.44
|
224.88
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.60
|
6.00
|
9.50
|
5.50
|
4.50
|
5.25
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
94.79
|
67.69
|
46.53
|
2.55
|
16.37
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
78.62
|
50.67
|
43.59
|
-8.31
|
5.03
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
32.85
|
30.08
|
18.06
|
4.86
|
13.99
|
|
|
|
|
|
|
ROE (%)
|
12.81
|
27.98
|
25.88
|
15.66
|
4.06
|
11.27
|
|
|
|
|
|
|
ROA (%)
|
10.29
|
24.35
|
22.13
|
13.29
|
3.43
|
9.43
|
|
|
|
|
|
|
EBIT Margin (%)
|
24.56
|
44.22
|
39.13
|
27.63
|
6.22
|
23.73
|
|
|
|
|
|
|
Net Margin (%)
|
26.82
|
39.35
|
33.64
|
25.23
|
8.32
|
20.50
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
44.47
|
36.36
|
30.51
|
14.10
|
26.84
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-20.73
|
10.77
|
47.72
|
39.20
|
-5.23
|
7.16
|
|
|
|
|
|
|
EBIT Growth (%)
|
-50.05
|
25.18
|
109.20
|
518.61
|
-75.17
|
0.85
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-32.59
|
35.66
|
94.09
|
320.76
|
-61.57
|
-3.43
|
|
|
|
|
|
|
EPS Growth (%)
|
-32.59
|
35.81
|
97.88
|
320.76
|
-61.44
|
-4.58
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
29.97
|
20.09
|
14.40
|
3.80
|
9.44
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
12.98
|
7.57
|
12.27
|
14.38
|
81.30
|
34.16
|
|
|
|
|
|
|
Price / Book Value
|
1.59
|
1.88
|
2.91
|
2.11
|
3.24
|
3.67
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.60
|
0.75
|
1.00
|
0.98
|
0.59
|
0.64
|
|
|
|
|
|
|
EV/EBITDA
|
10.40
|
4.85
|
8.75
|
9.52
|
38.67
|
21.19
|
|
|
|
|
|
|
Close Price (₹)
|
931.30
|
798.75
|
952.05
|
563.35
|
756.15
|
825.55
|
|
|
|
|
|
|
High Price (₹)
|
1,226.80
|
1,639.00
|
1,108.35
|
848.40
|
1,189.00
|
996.00
|
|
|
|
|
|
|
Low Price (₹)
|
789.00
|
757.05
|
540.10
|
502.00
|
750.45
|
491.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
14,848.21
|
14,278.94
|
17,031.69
|
10,286.71
|
13,820.73
|
15,058.99
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.04
|
0.06
|
0.03
|
0.09
|
0.06
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.04
|
0.06
|
0.03
|
0.09
|
0.06
|
|
|
|
|
|
|
Current Ratio
|
3.01
|
5.59
|
4.14
|
4.39
|
3.50
|
4.46
|
|
|
|
|
|
|
Quick Ratio
|
2.47
|
4.77
|
3.47
|
3.35
|
2.49
|
3.04
|
|
|
|
|
|
|
Interest Coverage
|
24.75
|
96.87
|
88.16
|
60.44
|
12.42
|
44.58
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
25.29
|
28.14
|
29.73
|
31.62
|
31.91
|
20.12
|
|
|
|
|
|
|
Asset Turnover
|
0.35
|
0.62
|
0.69
|
0.54
|
0.45
|
0.44
|
|
|
|
|
|
|
Receivable days
|
--
|
93.30
|
86.16
|
93.53
|
85.10
|
84.44
|
|
|
|
|
|
|
Inventory Days
|
--
|
56.17
|
60.81
|
95.32
|
128.47
|
118.77
|
|
|
|
|
|
|
Payable days
|
--
|
145.20
|
136.43
|
133.18
|
106.38
|
151.52
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
4.27
|
10.54
|
55.67
|
107.20
|
51.68
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
